Methoxyflurane inhalation vapour in trauma pain: a profile of its use in the EU Hannah A. BlairJames E. Frampton Adis Drug Q&A 31 July 2017 Pages: 403 - 408
Sufentanil sublingual tablet system in the treatment of acute postoperative pain in adults: a profile of its use Katherine A. Lyseng-WilliamsonJames E. Frampton Adis Drug Q&A 31 July 2017 Pages: 409 - 417
When treating chronic pelvic pain in women, consider peripheral and central contributors Adis Medical Writers Disease Management 13 July 2017 Pages: 418 - 423
Treat elderly patients hospitalized for community-acquired pneumonia early based on infection severity and risk factors Adis Medical Writers Disease Management 12 July 2017 Pages: 424 - 428
First reports of adverse drug reactions Drug Reactions and Interactions 07 August 2017 Pages: 429 - 429
Reduce the risk of QT interval prolongation associated with targeted cancer therapy by using arrhythmic risk stratification and prevention strategies Adis Medical Writers Drug Reactions and Interactions 13 July 2017 Pages: 430 - 434
Suspicious drug hypersensitivity reactions in pediatric patients: a retrospective single-center study Pinar Gokmirza OzdemirMehtap Yazicioglu Short Communication 20 July 2017 Pages: 435 - 441
May direct-acting antiviral regimens for chronic hepatitis C virus infections have neuropsychiatric adverse drug reactions? A pilot study conducted in patients receiving sofosbuvir-based regimens in the real-life setting Davide SimeoneAnna Maria SperaR. Orlando Original Research Article 06 July 2017 Pages: 442 - 447
Erratum to: Buprenorphine oral lyophilisate (Espranor®) in the substitution treatment of opioid dependence: a profile of its use Katherine A. Lyseng-Williamson Erratum 27 July 2017 Pages: 448 - 448
